Other
U.S. federal statutory tax
Vertex Pharmaceuticals U.S. federal statutory tax remained flat by 0.0% to $0.05 in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $0.05 to $0.05. Over 2 years (FY 2023 to FY 2025), U.S. federal statutory tax shows relatively stable performance with a 0.0% CAGR.
Analysis
StatementCash Flow Statement
SectionOther
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026
How to read this metric
Used to evaluate how much the company's actual tax rate deviates from the standard federal rate due to specific tax policies or credits.
Detailed definition
The reconciliation of the company's effective tax rate to the statutory federal tax rate. It highlights the impact of fe...
Peer comparison
Standard disclosure in the tax footnote for all US corporations.
Metric ID:
other_effective_income_tax_rate_reconciliation_at_federa_740d47Historical Data
3 years
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $0.21 | $0.21 | $0.21 |
| YoY Change | — | +0.0% | +0.0% |
Range$0.21 – $0.21
CAGR+0.0%
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak2+ years growth
U.S. federal statutory tax at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's u.s. federal statutory tax?
- Vertex Pharmaceuticals (VRTX) reported u.s. federal statutory tax of $0.05 in Q4 2025.
- How has Vertex Pharmaceuticals's u.s. federal statutory tax changed year-over-year?
- Vertex Pharmaceuticals's u.s. federal statutory tax decreased by 0.0% year-over-year, from $0.05 to $0.05.
- What is the long-term trend for Vertex Pharmaceuticals's u.s. federal statutory tax?
- Over 2 years (2023 to 2025), Vertex Pharmaceuticals's u.s. federal statutory tax has grown at a 0.0% compound annual growth rate (CAGR), from $0.21 to $0.21.
- What does u.s. federal statutory tax mean?
- The base federal tax rate applied to the company's earnings.